The Evolution and Management of Migraine Recurrence Beyond 24 Hours
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00754611
Verified February 2010 by Rutgers, The State University of New Jersey. Recruitment status was: Active, not recruiting
: September 18, 2008
Last Update Posted
: February 4, 2010
University of Medicine and Dentistry of New Jersey
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients at the University Headache Center, aged 18 or older, with a diagnosis of migraine with and/or without aura as defined by ICHD-II criteria
Female and male patients at University Headache Center with > 6 month diagnosis of migraine with and/or without aura (ICHD-II)
Greater than or equal to 18 years old
Greater than 15 days/month total headache days
Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)